Nothing Special   »   [go: up one dir, main page]

HK1220194A1 - 去氮雜去鐵硫代黴素 類似物的多晶型形式 - Google Patents

去氮雜去鐵硫代黴素 類似物的多晶型形式

Info

Publication number
HK1220194A1
HK1220194A1 HK16108274.2A HK16108274A HK1220194A1 HK 1220194 A1 HK1220194 A1 HK 1220194A1 HK 16108274 A HK16108274 A HK 16108274A HK 1220194 A1 HK1220194 A1 HK 1220194A1
Authority
HK
Hong Kong
Prior art keywords
desazadesferrithiocin
analogs
polymorph forms
polymorph
forms
Prior art date
Application number
HK16108274.2A
Other languages
English (en)
Inventor
TENJARLA Srini
Mcgee Paul
Original Assignee
Ferrokin Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrokin Biosciences Inc filed Critical Ferrokin Biosciences Inc
Publication of HK1220194A1 publication Critical patent/HK1220194A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/04Chelating agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HK16108274.2A 2013-03-15 2016-07-14 去氮雜去鐵硫代黴素 類似物的多晶型形式 HK1220194A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361789220P 2013-03-15 2013-03-15
PCT/US2014/026365 WO2014143630A1 (en) 2013-03-15 2014-03-13 Polymorph forms of desazadesferrithiocin analogs

Publications (1)

Publication Number Publication Date
HK1220194A1 true HK1220194A1 (zh) 2017-04-28

Family

ID=50514047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108274.2A HK1220194A1 (zh) 2013-03-15 2016-07-14 去氮雜去鐵硫代黴素 類似物的多晶型形式

Country Status (7)

Country Link
US (1) US9512095B2 (zh)
EP (1) EP2970162A1 (zh)
JP (1) JP2016513652A (zh)
AU (1) AU2014228308A1 (zh)
CA (1) CA2905026A1 (zh)
HK (1) HK1220194A1 (zh)
WO (1) WO2014143630A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970162A1 (en) 2013-03-15 2016-01-20 Ferrokin Biosciences, Inc. Polymorph forms of desazadesferrithiocin analogs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1866296B1 (en) 2005-04-04 2016-11-02 University of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
AU2008229472B2 (en) 2007-03-15 2013-03-14 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
MY163516A (en) 2008-07-14 2017-09-15 Ferrokin Biosciences Inc Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
JP2013500342A (ja) 2009-07-27 2013-01-07 フェロキン バイオサイエンシーズ,インク. 金属キレート化剤としてのデサザデスフェロチオシンポリエーテルアナログのプロドラッグ
WO2011140232A2 (en) 2010-05-04 2011-11-10 Ferrokin Biosciences, Inc Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
EP2787994A4 (en) 2011-12-09 2015-08-26 Ferrokin Biosciences Inc ORAL FORMULATIONS FOR TREATING METAL OVERLOAD
TW201427962A (zh) 2012-12-07 2014-07-16 Ferrokin Biosciences Inc 脫氮雜去鐵硫辛(desazadesferrithiocin)類似物之多晶型形式
EP2970162A1 (en) 2013-03-15 2016-01-20 Ferrokin Biosciences, Inc. Polymorph forms of desazadesferrithiocin analogs

Also Published As

Publication number Publication date
EP2970162A1 (en) 2016-01-20
US20160024034A1 (en) 2016-01-28
JP2016513652A (ja) 2016-05-16
CA2905026A1 (en) 2014-09-18
WO2014143630A1 (en) 2014-09-18
US9512095B2 (en) 2016-12-06
AU2014228308A1 (en) 2015-08-27

Similar Documents

Publication Publication Date Title
HK1222390A1 (zh) 抑制劑的多晶型
GB201421334D0 (en) Synthesis of aeizeolite
IL240677A0 (en) Solid forms of treprostinil
HK1216429A1 (zh) 用於純化芳基硫酸酯酶 的方法
HK1214240A1 (zh) 用於製備酰亞胺基二硫酰化合物的方法
GB2516136B (en) Colenterazine analogs
IL281072B (en) Processes for the preparation of pyrimidinylcyclopentane compounds
EP3003320A4 (en) NEW POLYMORPHE OF REGADENOSON
PL3063152T3 (pl) Dogodne wytwarzanie n-podstawionych morfinan-6-oli z morfinan-6-onów
HRP20182110T1 (hr) Sastav spojeva tiakumicina
HK1220194A1 (zh) 去氮雜去鐵硫代黴素 類似物的多晶型形式
EP2928469A4 (en) POLYMORPHIC FORMS OF DESAZADESFERRITHIOCIN ANALOGS
HK1216419A1 (zh) 合成方法
HK1217700A1 (zh) 多晶型物形式
PL3071575T3 (pl) Wytwarzanie normorfinanów
SG10201701021XA (en) Method of synthesis
HK1198422A1 (zh) 羊毛固醇三萜的新穎用途
GB201310660D0 (en) Synthesis of nucleosides